Home >> Current Pharmaceutical Design, Volume 15, Number 30
Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Related content
Volume 15, Number 30, October 2009

< previous issue | all issues | next issue >

Articles

Editorial [Hot topic: Phosphodiesterase-5 Inhibitors and their Use in the Treatment of Urological Conditions (Executive Editor: Perimenis Petros)]
pp. 3463-3463(1)
Author: Petros, Perimenis

PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile
pp. 3464-3475(12)
Authors: Kouvelas, D.; Goulas, A.; Papazisis, G.; Sardeli, C.; Pourzitaki, C.

Phosphodiesterase Type 5 Inhibitors: Unmet Needs
pp. 3476-3485(10)
Authors: Hatzimouratidis, K.; Hatzichristou, D. G.

Phosphodiesterase Type 5 Inhibitors for the Management of Erectile Dysfunction: Preference and Adherence to Treatment
pp. 3486-3495(10)
Authors: Al-Shaiji, T. F.; Brock, G. B.

Prophylaxis of Erectile Function After Radical Prostatectomy with Phosphodiesterase Type 5 Inhibitors
pp. 3496-3501(6)
Authors: Deho, F.; Gallina, A.; Salonia, A.; Briganti, A.; Suardi, N.; Zanni, G.; Guazzoni, G.; Rigatti, P.; Montorsi, F.

PDE5 Inhibitors in the Treatment of LUTS
pp. 3502-3505(4)
Author: Speakman, M. J.

Is There a Role for PDE5 Inhibitors in the Management of Male Infertility Due to Defects in Testicular or Epididymal Function?
pp. 3506-3520(15)
Authors: Dimitriadis, F.; Tsounapi, P.; Saito, M.; Watanabe, T.; Sylakos, A.; Tsabalas, S.; Miyagawa, I.; Sofikitis, N.

PDE5 Inhibitors in Non-Urological Conditions
pp. 3521-3539(19)
Authors: Vlachopoulos, C.; Terentes-Printzios, D.; Ioakeimidis, N.; Rokkas, K.; Stefanadis, C.

Phosphodiesterase-5 Inhibitors: Future Perspectives
pp. 3540-3551(12)
Authors: Konstantinos, Giannitsas; Petros, Perimenis

Recent Advances of Fluorescent Technologies for Drug Discovery and Development
pp. 3552-3570(19)
Authors: Chakraborty, Chiranjib; Hsu, Chi-Hsin; Wen, Zhi-Hong; Lin, Chan-Shing

Role of Calcitonin Gene-Related Peptide in Gastric Mucosal Defence and Healing
pp. 3571-3576(6)
Author: Evangelista, S.

Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides
pp. 3577-3589(13)
Authors: Leali, D.; Alessi, P.; Coltrini, D.; Rusnati, M.; Zetta, L.; Presta, M.

< previous issue | all issues | next issue >

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page